Popular Blood Pressure Drug Raises Skin Cancer Risk
A common blood pressure drug may raise your skin cancer risk, say Danish researchers in a study published in the Journal of the American Academy of Dermatology. The drug, hydrochlorothiazide (HCTZ), which is one of the most common medications used to treat high blood pressure worldwide, is associated with a seven times higher risk of non-melanoma skin cancer.
For this study, researchers at the University of Southern Denmark in Odense looked at data on more than 80,000 people diagnosed with non-melanoma skin cancer from a national database in Denmark. They compared people using HCTZ (Microzide, Esidrix, Diovan) and other antihypertensives with 1.5 million healthy individuals and discovered that those who took hydrochlorothiazide were as much as seven times more likely to develop both squamous cell carcinoma and basal cell carcinoma. Other blood pressure medications studied did not increase the risk, according to the researchers.